Leon Bichmann (@lbichmann) 's Twitter Profile
Leon Bichmann

@lbichmann

Bioinformatics, Mass Spectrometry, Vaccines, Drug Discovery
(@BioNTech_Group - views are my own)

ID: 998087921973583873

calendar_today20-05-2018 06:27:58

118 Tweet

198 Takipçi

446 Takip Edilen

Philipp Lange (he/him) (@philipplange.bsky.social) (@lange_lab) 's Twitter Profile Photo

We are hiring - please RT. We have fully funded PostDoc and PhD level staff scientist (RA) positions waiting for inquisitive minds. #ChildhoodCancer #Proteomics #PrecisionMedicine. Details langelab.med.ubc.ca/open-positions. DM for questions.

BioNTech SE (@biontech_group) 's Twitter Profile Photo

Our collaborator Zipline completed the 1st long-range drone delivery of our #COVID19 vaccine in Ghana. This underlines our shared focus to pioneer solutions to address COVID-19 vaccine access challenges in low & lower-middle income countries. investors.biontech.de/news-releases/…

Our collaborator <a href="/zipline/">Zipline</a> completed the 1st long-range drone delivery of our #COVID19 vaccine in Ghana. This underlines our shared focus to pioneer solutions to address COVID-19 vaccine access challenges in low &amp; lower-middle income countries. investors.biontech.de/news-releases/…
QBiC | @qbic_tue@genomic.social (@qbic_tue) 's Twitter Profile Photo

We're looking for a Bioinformatician / Python developer to join us and contribute to the nf-core project as a core developer 👩‍💻👨‍💻. Apply until December 20th! uni-tuebingen.de/en/research/re…

Paul Bröckelmann (@broeckelmannpj) 's Twitter Profile Photo

Interestingly analysis Nature Cancer by Penn Medicine - Abramson Cancer Center establishing "The Cancer Surfaceome Atlas" (fcgportal.org/TCSA) & identifying actionable targets across tissues and tumor entities based on integrative analysis of single-cell and bulk genomic data go.nature.com/3s5EOx9

Interestingly analysis <a href="/NatureCancer/">Nature Cancer</a> by <a href="/PennCancer/">Penn Medicine - Abramson Cancer Center</a>  establishing "The Cancer Surfaceome Atlas" (fcgportal.org/TCSA) &amp; identifying actionable targets across tissues and tumor entities based on integrative analysis of single-cell and bulk genomic data go.nature.com/3s5EOx9
Etienne Caron (@etiennecaron15) 's Twitter Profile Photo

Happy to share our latest paper about the constitutive biogenesis of the MHC class I immunopeptidome across primary tissues! HUPO-HIPP Human Proteome Cell Press sciencedirect.com/science/articl…

Happy to share our latest paper about the constitutive biogenesis of the MHC class I immunopeptidome across primary tissues! <a href="/HippHupo/">HUPO-HIPP</a> <a href="/hupo_org/">Human Proteome</a> <a href="/CellPressNews/">Cell Press</a>  sciencedirect.com/science/articl…
Minkyung Baek (@minkbaek) 's Twitter Profile Photo

We opened a new Research Topic in Frontiers in Immunology on "Structural modeling and computational analyses of immune system molecules". Please submit an abstract (by Feb 22) for a paper or review you'd like to see published! More info: frontiersin.org/research-topic…

Wout Bittremieux (@wout@sigmoid.social) (@bittremieux) 's Twitter Profile Photo

Registration for the EuBIC-MS 2022 Winter School is now open! Join us to learn about the hottest computational mass spectrometry research from keynote speakers such as Karl Mechtler, @boeckerlab, Isabell Bludau, v_dorfer, Magnus Palmblad, CompOmics, Pedro Beltrao, and more.

EFIS (@efis_immunology) 's Twitter Profile Photo

Are you a PhD student or postdoc looking to learn a new technique? Then why not think about applying for an EFIS-Immunology Letters short-term fellowship! Have a look at the details 👉 buff.ly/34G6rkx and make sure to submit your application before 12 March!

Are you a PhD student or postdoc looking to learn a new technique? Then why not think about applying for an EFIS-Immunology Letters short-term fellowship! 

Have a look at the details 👉 buff.ly/34G6rkx and make sure to submit your application before 12 March!
Leon Bichmann (@lbichmann) 's Twitter Profile Photo

Heute um 20.30 Uhr gilt: #LichtAus für einen friedlichen & lebendigen Planeten. #EarthHour mitmachen.wwf.de/earth-hour-202…

Meissner_Lab (@meissner_lab) 's Twitter Profile Photo

Great to see our review article on 'The emerging role of mass spectrometry-based proteomics in drug discovery' published Nature Reviews Drug Discovery: nature.com/articles/s4157… Thanks Marcus, Jennifer, and Matthias!

OpenMS Team (@openmsteam) 's Twitter Profile Photo

We are excited to announce our summer 2022 fellowship!! Great opportunity for grad students with #MassSpec background to receive training in #CompMS. The application deadline is May 6. #AcademicTwitter #opensource #proteomics #Metabolomics #Lipidomics #TeamMassSpec

We are excited to announce our summer 2022 fellowship!! Great opportunity for grad students with #MassSpec background to receive training in #CompMS. The application deadline is May 6. 

#AcademicTwitter #opensource #proteomics #Metabolomics #Lipidomics #TeamMassSpec
Lauren Stopfer, PhD (@lstops) 's Twitter Profile Photo

Our proteomics team BioNTech SE in Cambridge, MA is expanding! We’re looking for a motivated, curious scientist to join our group. Interested? Apply or DM me! jobs.biontech.de/Scientist-Prot…

Michal Bassani-Sternberg (@michal_bassani) 's Twitter Profile Photo

The application deadline for the 2nd Human ImmunoPeptidome Summer School (HUPO-HIPP) in Oxford is approaching! The summer school is a must event for experienced and beginners working on MS-based immunopeptidomics. Big thanks to all our fantastic speakers! …hipp-summer-school.mailchimpsites.com

Impens Lab (@impenslab) 's Twitter Profile Photo

Finally published! Thank you all co-authors for their priceless contribution! Here we designed mRNA vaccine formulations against Listeria using immunopeptidomics Looking forward to continue our efforts to tackle other intracellular bacterial pathogens tinyurl.com/vaccineListeria

Leon Bichmann (@lbichmann) 's Twitter Profile Photo

Following the recent developments on twitter I am putting my account on pause and will not actively use it anymore for a while